| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2004 | Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia | Chen, CP; Chen, CY; Yang, YC; Su, TH; Chen, H | Placenta 25, 413-421 | | | |
| 2013 | Distribution of the Galbeta1-4Gal Epitope among Birds: Species-Specific Loss of the Glycan Structure in Chicken and Its Relatives. | Suzuki, N; Nawa, D; Su, TH; Lin, CW; Khoo, KH ; Yamamoto, K | PloS one 8(3), e59291 | | | |
| 2013 | Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients | Cheng, HR; Liu, CJ; Tseng, TC; Su, TH; Yang, HI; Chen, CJ; Kao, JH | PLoS One 8:e53008 | | | |
| 2016 | Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis | Yang, HI ; Tseng, TC; Liu, J; Lee, MH; Liu, CJ; Su, TH; Batrla-Utermann, R; Chan, HL; Kao, JH; Chen, CJ | Clinical gastroenterology and hepatology 14(3), 461-468.e2 | | | |
| 2013 | Prostaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARgamma activity. | Yu, YH; Chang, YC; Su, TH; Nong, JY; Li, CC; Chuang, LM | Journal of lipid research 54(9), 2391-9 | | | |
| 2020 | Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. | Yang, HI ; Yeh, ML; Wong, GL; Peng, CY; Chen, CH; Trinh, HN; Cheung, KS; Xie, Q; Su, TH; Kozuka, R; Lee, DH; Ogawa, E; Zhao, C; Ning, HB; Huang, R; Li, J; Zhang, JQ; Ide, T; Xing, H; Iwane, S; Takahashi, H; Wong, C; Wong, C; Lin, CH; Hoang, J; le, A; Henry, L; Toyoda, H; Ueno, Y; Gane, EJ; Eguchi, Y; Kurosaki, M; Wu, C; Liu, C; Shang, J; Furusyo, N; Enomoto, M; Kao, JH; Yuen, MF; Yu, ML; Nguyen, MH | The Journal of infectious diseases 221(3), 389-399 | | | |
| 2021 | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, W; Chang, TT; Yang, HI ; Peng, CY; Su, CW; Su, TH; Hu, TH; Yu, ML; Yang, HC; Wu, JC | Hepatology international 15, 1421-1430 | | | |
| 2009 | Structural analysis of N-glycans from gull egg white glycoproteins and egg yolk IgG. | Suzuki, N; Su, TH; Wu, SW; Yamamoto, K; Khoo, KH ; Lee, YC | Glycobiology 19(7), 693-706 | | | |
